Visualizing podocyte foot processes requires electron microscopy, a technique that depends on special equipment, requires immunogold for colabeling, and does not take advantage of the growing number of in vivo fluorophores available. To address these limitations, we developed a genetic strategy to allow detailed visualization of single podocytes and their foot processes by conventional fluorescence microscopy. We generated a transgenic mouse line expressing a GFP-Cre-ERT2 fusion protein under the control of the collagen a1(I) promoter with strong podocyte expression. Administration of submaximal tamoxifen allowed genetic labeling of single podocytes when crossed with a Cre-reporter line. Of three different reporter systems that we evaluated for the ability to reveal fine structural details of podocytes, bigenic Coll1a1GCE;Gt(ROSA)26Sor tm9(CAG-tdTomato) mice allowed podocyte labeling with a strong and homogeneous reporter signal that was easily observed by epifluorescence. We could easily detect anatomic features of podocytes down to tertiary foot processes, and we were able to visualize and quantitate ultrastructural changes to foot processes after podocyte injury. In summary, using this method of genetic labeling and conventional fluorescence microscopy to visualize podocyte foot processes will complement electron microscopy and facilitate the analysis of podocytes and their precursors in vivo.
Podocytes are highly differentiated epithelial cells that constitute the visceral layer of Bowman's capsule and are on the outside of the underlying capillary loop. The unique podocyte anatomy in vivo is characterized by a cell body, major (primary and secondary) processes, and a multitude of minor (tertiary) foot processes that interdigitate with neighboring foot processes, contributing to the glomerular filtration barrier (GFB). This barrier allows water, solutes, and smaller proteins to cross from the capillary lumen into Bowman's space, thereby generating the primary filtrate. Podocyte function and structure are increasingly accepted as key determinants of GFB integrity, giving rise to the concept of podocytopathies as the common origin of glomerular diseases such as FSGS and minimal change disease. 1 Glomerular diseases characterized by high-grade, nephrotic-range proteinuria are accompanied or preceded by ultrastructural changes in podocyte morphology and in the case of minimal change disease, may be the only detectable histologic abnormality. These lesions consist of lateral spreading and flattening, retraction, and shortening of foot processes, known as effacement or fusion. 2, 3 Because these changes cannot be appreciated by light microscopy, our knowledge of architectural fine structures of podocytes and capability to assess their alteration relies on electron microscopic (EM) studies. However, EMs are not routinely available laboratory equipment. Other imaging technologies such as multiphoton or subdiffraction microscopy are being developed, but they are greatly limited by low throughput and at present they are not available for routine use. 4, 5 Conventional fluorescence microscopes have become standard laboratory equipment, although resolution of fine structures in the submicrometer range remains challenging with this technique, owing mainly to an inadequate signal to noise ratio and diffraction. In this study, we asked whether a strategy to genetically label single podocytes would yield sufficient optical contrast between labeled and adjacent unlabeled processes to detect anatomic details down to the tertiary foot process level.
We generated a new conditional Cre driver mouse that expresses a GFP-Cre-ERT2 (GCE) fusion protein under the control of the collagen1a1 promoter, 6, 7 which was previously shown to drive expression in podocytes and interstitial pericytes. 8 We crossed this mouse with three different Cre reporter lines to (1) explore Cre-LoxP recombination efficiency in podocytes in relation to tamoxifen/4-hydroxytamoxifen (4-OHT) administration and (2) evaluate these reporter systems for their ability to reveal fine morphologic details of these cells ( Figure 1A) .
The first reporter that we tested was the widely used R26LacZ [Gt(ROSA) 26Sor tm1Sor ] mouse, in which Cre-mediated removal of an LoxP-flanked STOP sequence results in expression of a lacZ gene and thus, production of b-galactosidase. 9 Cells with b-galactosidase production are identified by the appearance of a blue pigment after incubation with X-galactosidase ( Figure 1B) .
The second reporter that we used was the mT/mG [Gt(ROSA) 26Sor tm4(ACTB-tdTomato,-EGFP)Luo ] mouse, in which ubiquitously expressed membranetargeted tdTomato (mT) is replaced by membrane-targeted enhanced green fluorescent protein (mG) after Cre-mediated deletion of the mT cassette ( Figure 1C ). 10 The third reporter that we examined was the recently developed R26Tomato [Gt(ROSA)26Sor
] mouse, in which excision of an LoxP-flanked STOP cassette induces strong expression of tdTomato, a nonoligomerizing DsRed fluorescent protein variant. The R26Tomato line was originally designed to enhance visibility of distinctive morphologies of brain cells ( Figure 1D and Supplemental Video 1). 11 To evaluate podocyte recombination efficiency in Coll1a1GCE mice, we treated pups bigenic for Coll1a1GCE and a reporter allele with subcutaneous injections of tamoxifen or 4-OHT. Repeated pulsing resulted in efficient labeling of the majority of podocytes in all three reporter lines, whereas a single bolus dose of 0.1-0.5 mg tamoxifen/4-OHT Single injection at P3 resulted in a more homogenous but mostly partial labeling of glomeruli throughout the cortex. By contrast, repeated tamoxifen/4-OHT injections (P0 and P3) labeled the majority of podocytes in almost all glomeruli. Quantitation was performed in Coll1a1GCE + ;mT/mG + and Coll1a1GCE + ;R26Tomato + mice, respectively. Data are given as mean 6 SEM; n=3-4 for each data point.
injected into pups between postnatal days 0 and 7 (P0-P7) gave a moderate labeling frequency, leaving many glomeruli only partially recombined (Figure 1 , E-G). Immunostaining showed that labeled glomerular cells were nephrinpositive but CD31-and PDGFRbnegative, verifying their podocyte cell identity (Figure 2) .
We hypothesized that genetic labeling of single podocytes rather than the whole podocyte network would enhance the optical contrast between labeled foot processes, because the neighboring unlabeled foot processes would remain optically silent (Supplemental Figure 1) . Analysis of labeled podocytes in Coll1a1GCE + ; R26LacZ + and Coll1a1GCE + ;mT/mG + mice proved that these reporters were unsuitable for the visualization of distinct structures by light or fluorescence microscopy, respectively. In striking contrast, sporadically labeled podocytes in Coll1a1GCE + ;R26Tomato + kidneys had a distinctive fluorescent pattern: the fluorochrome tdTomato produced very bright epifluorescence and was uniformly distributed throughout the cell, with brightest fluorescence in the cell body that corresponded to the larger cell volume in that region. Conventional fluorescence microscopy was adequate to image all aspects of the podocyte, including primary, secondary, and tertiary foot processes, and morphometric analyses of single podocytes were in accordance with dimensions documented by EM studies (Figures 3 and 4 , L-P and Supplemental Video 2). 3, 12 Confirming our original hypothesis, when two podocytes adjacent to each other were each labeled, individual foot processes could no longer be distinguished ( Figure 3D ). For this reason, sparse podocyte labeling of three to five podocytes per glomerular section was optimal for podocyte foot process visualization. Tertiary foot processes could be visualized in ;67% of podocytes, with secondary and primary foot processes observable in a larger fraction of total podocytes (Supplemental Figure 2) .
Importantly, simultaneous immunostaining did not interfere with our ability to capture podocyte details. Staining for laminin, for instance, showed a close association of the foot process network with the glomerular basement membrane (Figure 3, A-C and H-K) . Three-dimensional reconstruction confirmed that labeled pedicles, as expected, surrounded capillary-like structures ( Figure 3 , H-K; Supplemental Video 3). Costaining for either nephrin or F-actin revealed the colocalization of foot processes with both known foot process proteins (Supplemental Figure 3) .
Next, we assessed whether this model could be used to directly visualize structural changes of podocytes. We used the well established model of protamine sulfate (PS) perfusion [13] [14] [15] [16] [17] to induce foot process effacement in Coll1a1GCE + ; R26Tomato + mice and compared them with mice with uninjured kidneys. We found that ultrastructural alterations, including foot process widening and shortening, were readily visible after PS exposure and quantifiable by simple measurements (Figure 4 and Supplemental Figure 4 ). These foot process changes closely resembled the phenomenon of lateral spreading, which has previously been characterized in this injury model by scanning EM. 17 We could exclude the possibility that an adjacent, superposed foot process from a second labeled podocyte might account for the appearance of lateral spreading, because 49,6-diamidino-2-phenylindole counterstaining followed by three-dimensional reconstruction showed that only one labeled podocyte was present in the glomerular region imaged.
In summary, we have developed a novel approach to image and measure podocyte foot processes in vivo by conventional fluorescence microscopy. This technique should be useful for the study of podocyte biology in several ways. First, this tool will facilitate the localization of foot process proteins in vivo by immunofluorescence microscopy, which is less cumbersome than immunogold labeling. However, EM will remain an important tool for the study of podocyte biology. Limitations of the approach that we describe relate primarily to the diffraction limit, which precludes visualization of ultrafine structures, such as changes of the GFB or the subpodocyte space and the detection of subtle differences in foot process morphology. These analyses as well as the evaluation of subcellular units, including organelles, will continue to require EM. Second, it allows quantitation of podocyte injury using widely available laboratory techniques and equipment. Third, and potentially most importantly, this genetic approach can be combined with conditional alleles to help understand how individual podocytes acquire their intricate morphology and how genetic mutations lead to foot process effacement. In the case of a floxed null allele, application of submaximal tamoxifen will create a glomerulus mosaic for WT and mutant podocytes, with the reporter expressed only in those podocytes that are knocked out for the gene of interest, allowing for their simple identification and analysis. It should be noted that application of this technique to podocyte-specific mouse mutant models would require at least three alleles, and the breeding of such mice is time-consuming and expensive. Some podocytopathy models require a specific background strain, which is another limitation. Finally, this technique may be useful in studying podocyte progenitor pools. Recent reports indicate that parietal epithelial cells of Bowman's capsule may represent a progenitor pool for podocytes in mature kidneys. [18] [19] [20] [21] [22] It has also been proposed that bone marrow-derived cells may offer another source of podocyte recruitment. 23, 24 These studies have used fate marker expression, glomerular tuft localization, and podocyte protein expression to define the cells as podocytes. Coupled with the appropriate CreER driver, using the tdTomato reporter in these studies would enable an analysis of the foot process morphology of these new podocytes-arguably the most stringent criterion for podocyte cellular identity. Such an analysis might answer whether the progenitor-derived podocytes truly integrate into the existing podocyte foot process network, becoming a functional part of the GFB.
CONCISE METHODS
Coll1a1GCE transgenic mice were generated using standard techniques; comprehensive details of this line will be documented elsewhere (I.G. and B.D.H., unpublished data). Cre-reporter lines R26LacZ, mT/mG, and R26Tomato were obtained from The Jackson Laboratory (stock numbers 9427, 7576, and 7914, respectively; Bar Harbor, ME). Mice were maintained on a mixed C57Bl6/129sv background. Genotyping of all mice was performed by PCR. Tamoxifen (Sigma) or its active metabolite 4-OHT (Sigma) was dissolved in 3% ethanol-containing cornoil (Sigma) at a concentration of 10 mg/ml. Solutions were heated at 45°C for 20-30 minutes until the compounds were completely dissolved. Pups (P0-P7) were subjected to subcutaneous injection of either tamoxifen/ 4-OHT (P0=0.1 mg; P3=0.25 mg; P7=0.5 mg) or the same volumes of vehicle only. Animals were sacrificed at 6-10 weeks of age, and kidneys were harvested and processed for histologic analyses as previously described. 25 Cryosections were mounted on Fisher Superfrost Plus (Fisher) microscope slides, immunostained if indicated, and mounted in ProLong Gold Antifade containing 49,6-diamino-2-phenylindole (Invitrogen). LacZ activity was determined by standard X-galactosidase staining, and sections were counterstained with nuclear fast red solution before mounting. FITC-conjugated phalloidin (1:500; Invitrogen) was used to probe for F-actin. The following primary antibodies were used for immunostaining: guinea pig antinephrin (1:100; Progen Biotechnik), rat anti-CD31 (1:100; eBioscience), rat anti-PDGFRb (1:200; eBioscience), and rabbit antilaminin (1:500; Sigma). Sections were subsequently exposed to corresponding Cy5/DyLight649-conjugated secondary antibodies (Jackson ImmunoResearch). For induction of foot process effacement, mouse kidneys were perfused with PS as described elsewhere. [15] [16] [17] For visualization and morphometric analysis, mounted kidney sections of 5-to 7-mm thickness were imaged using a Nikon C1 D-Eclipse confocal microscope or a Nikon Eclipse Ti inverted fluorescence microscope and 603 or 1003 objectives. z-Stacks were collected at 0.2-mm intervals for a total of 6-8 mm. To obtain high-quality images of foot processes, the z-stacks were processed and recombined using Nikon NIS elements software with an extended depth of focus algorithm to obtain a focused or three-dimensional reconstructed image; 10-30 glomeruli were captured per kidney section in a random fashion. Morphometric analyses were performed using Nikon NIS elements software. Podocyte cell body area measurements excluded primary, secondary, and tertiary processes. Widths of primary and secondary processes were measured at more than or equal to three different positions, and the mean was determined. Lengths of tertiary foot processes were measured from base to tip; widths of tertiary foot processes were measured at the pedicle's apical third. Data are presented as mean 6 SEM if not otherwise indicated. Statistical analysis was performed using the unpaired t test. P values of ,0.05 were considered statistically significant.
